• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News

    Global Vaccination Efforts Facing 'Acute Cash Crisis'

    By Chiden Balmes // 12 May 2010

    The Global Alliance for Vaccines and Immunization is facing an “acute cash crisis” as the prices of life-saving vaccines surged while donor contributions stagnated. This is the main finding of the report published by the Doctors Without Borders and Oxfam International.

    The 31-page report, entitled “Giving Developing Countries the Best Shot: An Overview of Vaccine Access and R&D,” revealed that health support to children in the poorest countries is experiencing an acute crisis. For instance, GAVI cannot provide most children with the pneumococcal conjugate vaccines, or PCVs, because of funding gaps.

    Oxfam Senior Policy Advisor Rohit Malpani said: “The newest vaccines continue to be produced by only a handful of multinational pharmaceutical companies whose oligopoly status allows them to charge high prices. Despite GAVI’s negotiating power, the price of new vaccines is too high.”

      Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

      About the author

      • Chiden Balmes

        Chiden Balmes

        Chiden, a correspondent based in Seoul, focuses on computer-assisted reporting to provide international development professionals with practical business and career information. He also contributes to the Development Newswire and the Global Development Briefing, two of the world's highest-circulation development publications.

      Search for articles

      Related Stories

      Devex NewswireDevex Newswire: Vatican endorses action plan for global debt relief

      Devex Newswire: Vatican endorses action plan for global debt relief

      Devex NewswireDevex Newswire: IMF austerity criticized for gutting Africa’s public services

      Devex Newswire: IMF austerity criticized for gutting Africa’s public services

      Devex NewswireDevex Newswire: Syria’s fragile recovery faces development funding cliff

      Devex Newswire: Syria’s fragile recovery faces development funding cliff

      Food SystemsAlready strapped for cash, WFP faces post-USAID future

      Already strapped for cash, WFP faces post-USAID future

      Most Read

      • 1
        How low-emissions livestock are transforming dairy farming in Africa
      • 2
        Opinion: Mobile credit, savings, and insurance can drive financial health
      • 3
        Opinion: India’s bold leadership in turning the tide for TB
      • 4
        How AI-powered citizen science can be a catalyst for the SDGs
      • 5
        Strengthening health systems by measuring what really matters
      • News
      • Jobs
      • Funding
      • Talent
      • Events

      Devex is the media platform for the global development community.

      A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Post a job
      • Careers at Devex
      • Contact us
      © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement